Q2 2025 Earnings Call Transcript August 1, 2025 Ocugen, Inc. beats earnings expectations. Reported EPS is $-0.05, ...

Trump’s tariff regime has shaken global trade — and Ireland’s critical pharma sector is bracing for long-term change ...

FDA granted Orphan Drug Designation to Sanofi’s SAR446523, a monoclonal antibody targeting GPRC5D, for relapsed/refractory ...

Amicus Therapeutics is building momentum with strong sales growth from GALAFOLD and POMBILITI/OPFOLDA. Click here to find out ...

In the Portal study (n = 352), people originally treated with Susvimo in Archway continued to receive Susvimo refills every six months (Susvimo cohort; n = 220), while those originally treated with ...

Eli Lilly's growth is fueled by GLP-1 blockbusters and a solid pipeline, yet high valuations and reliance on key drugs ...

President Donald Trump surprised pharma CEOs on Thursday with letters demanding they acquiesce to his most-favored ...

The FDA is requiring safety labeling changes to all opioid painkillers, to better highlight the risks posed by using the ...

Sources also say that the administration plans to split CBER in two, with one of the section focused entirely on vaccines.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Dr George Tidmarsh, a former pharmaceutical executive who joined the FDA this month, will take over Prasad’s role temporarily.

In line with President Donald Trump's “most favored nation” model, letters were sent Thursday to 17 of the world's biggest drug companies demanding price cuts for Americans and direct-to-consumer ...